Soluble Fas and Fas-ligand in bladder cancer in vitro and in vivo

Urologic Oncology

Volumn 6, Issue 4, 2001, Pages 163-169

  Perabo, Frank G E ^a   Mattes, Roland H ^b   Wirger, Andreas ^c   Steiner, Gabriel ^a   Kamp, Stefan ^a   Schmidt, Doris ^a   Pegelow, Katrin ^a   Von Ruecker, Alexander ^a   Müller, Stefan C ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Apoptosis; Bladder cancer; Fas ligand; Immune escape; Soluble Fas

Indexed keywords

COMPLEMENTARY DNA; FAS ANTIGEN; FAS LIGAND; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BLADDER CANCER; BLOOD LEVEL; CANCER CELL CULTURE; CANCER STAGING; CONTROLLED STUDY; CORRELATION FUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNITY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0034966921     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1078-1439(00)00130-7     Document Type: Article

References (32)

1. Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxcicity
2. Fas-mediated cytotoxicity by freshly isolated natural killer cells
3. 2+-independent T cell-mediated cytotoxicity
4. Apoptosis by death factor
5. To die or not to die; the quest of the TRAIL receptors
6. Three functional soluble forms of the human apoptosis-inducing Fas-molecule are produced by alternative splicing
7. Differential expression of human Fas mRNA species upon peripheral blood mononuclear cell activation
8. Autocrine T-cell suicide mediated by APO-1/(FasCD95)
9. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule
10. Soluble Fas/APO-1 in tumor cells; a potential regulator of apoptosis?
11. Resistance to Fas-mediated apoptosis in human hepatoma cells
12. Elevated soluble Fas (sFas) in nonhematopoetic human malignancy
13. Expression of the functional soluble form of human Fas ligand in activated lymphocytes
14. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand expressing tumor cells; A mechanism of immune evasion?
15. The Fas counterattack; Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
16. Human lung carcinoma express Fas ligand
17. Human pancreatic adenocarcinomas express Fas and Fas Ligand yet are resistant to Fas-mediated apoptosis
18. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer
19. Human colon cancer cells express the functional Fas ligand
20. Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligand
21. Melanoma cell expression of Fas (APO-1/CD95) ligand; Implication for tumor immune escape
22. Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis
23. Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
24. Fas ligand expression by astrocytoma in vivo; maintaining immune privilege in the brain?
25. Fas ligand expression in human glioblastoma cell lines and primary astrocytic brain tumors
26. Transitional cell carcinoma expresses high levels of Fas ligand in vivo
27. Molecular cloning and expression of a receptor for human tumor necrosis factor
28. Cloning of the human and murine interleukin-7 receptors; demonstration of a soluble form and homology to a new receptor superfamily
29. Fas ligand is present in tumors of the Ewing's sarcoma family and is cleaved into a soluble form by a metalloproteinase
30. Prognostic significance of soluble Fas in the serum of patients with bladder cancer
31. Fas ligand in human serum
32. Serum soluble Fas levels as a marker to distinguish allergic and nonallergic rhinitis